We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Don't Be Fooled by Drop in IPO ETFs: Road Ahead Looks Smooth
Read MoreHide Full Article
The IPO market remained super solid this year. Though Renaissance IPO ETF (IPO - Free Report) lost 3.1% on Dec 9 on broader market concerns, the prospect looks pretty upbeat. There have been 205 IPOs priced this year, up 34.9% from last year, per renaissancecapital. Total proceeds raised are $74.2 billion, up 70.2% from last year. About 247 IPOs were filed this year, marking an increase of 24.7% from last year.
There have been 220 SPAC IPOs this year, with healthcare taking half the total volume. Some of these newly public biotech companies are working on coronavirus vaccines and therapeutics and have thus been hugely popular with investors. The recent resurgence in blank check and Special Purchase Acquisition Companies (SPAC) has been one of the main reasons for the rally in IPO ETFs.
Among the recently priced IPOs, C3.ai (up 120.2%; offer date Dec 8, 2020), 17 Education & Tech (up 92.2%, offer date Dec 4, 2020), Seer (up 247.4%, offer date Dec 3, 2020), Kinnate Biopharma (up 126.3%, offer date Dec 2, 2020), Olema Pharmaceuticals (up 130.1%, offer date Nov 18, 2020), Praxis (up 124.3%, offer date Oct 15, 2020) are some that have seen a huge surge in returns from IPO.
Food & Lodging Hogging the IPO Limelight at Present
Many IPOs have seen huge success this year with the largest provider of food delivery services DoorDash DASHgrabbing attention currently.The stock gained 86% on its debut on Dec 9. Its $102 IPO price breezed past the estimated price range of $90 to $95.
Most importantly, the company initially filed to offer at a range of $75 to $85. The stock closed its first day on the New York Stock Exchange at $189 per share. Overall, DoorDash raised $3.4 billion with an initial public offering.
Apart from DoorDash, Airbnb ABNB is making quite a buzz. Its shares are likely to begin trading from Dec 10. It reportedly priced its initial public offering at $68 per share, in one of this year’s largest and highly anticipated IPOs.
Before this, Airbnb had planned to sell around 51 million shares at $56 to $60 per share, having boosted this range from an earlier target of $44 to $50 per share, per Reuters. The outlook looks promising for the company as with virus concerns prevailing, many travelers may be intending to book homes instead of hotels.
How to Invest?
Overall, the IPO pipeline is still solid. SPAC activity maintained the winning momentum. Against this backdrop, investors can bet on the following ETFs.
Defiance NextGen SPAC IPO ETF
The underlying Indxx SPAC & NextGen IPO Index of the fund SPAK tracks the performance of the common stock of newly listed Special Purpose Acquisition Companies (SPACs), ex-warrants, and IPOs derived from Acquisition Companies over the preceding 36 months.
An 80% weighting is attached to IPO companies derived from SPACs and 20% is allocated to the common stocks of newly listed Special Purpose Acquisition Companies. The fund charges 45 bps in fees.
The underlying Renaissance IPO Index is a portfolio of newly U.S.-listed IPOs of companies whose unseasoned equities are under-represented in core U.S. equity indices. Notably, IPOs that meet liquidity & operational screens are included on the index at the end of the fifth day of trading, or upon quarterly reviews, weighted by tradable float, capped at 10% and removed after two years. The fund charges 60 bps in fees.
The underlying Renaissance International IPO Index is a stock market index based upon a portfolio of non-U.S.-listed newly public companies, prior to their inclusion in global core equity portfolios. The fund charges 80 bps in fees. The fund charges 80 bps in fees.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Don't Be Fooled by Drop in IPO ETFs: Road Ahead Looks Smooth
The IPO market remained super solid this year. Though Renaissance IPO ETF (IPO - Free Report) lost 3.1% on Dec 9 on broader market concerns, the prospect looks pretty upbeat. There have been 205 IPOs priced this year, up 34.9% from last year, per renaissancecapital. Total proceeds raised are $74.2 billion, up 70.2% from last year. About 247 IPOs were filed this year, marking an increase of 24.7% from last year.
There have been 220 SPAC IPOs this year, with healthcare taking half the total volume. Some of these newly public biotech companies are working on coronavirus vaccines and therapeutics and have thus been hugely popular with investors. The recent resurgence in blank check and Special Purchase Acquisition Companies (SPAC) has been one of the main reasons for the rally in IPO ETFs.
Among the recently priced IPOs, C3.ai (up 120.2%; offer date Dec 8, 2020), 17 Education & Tech (up 92.2%, offer date Dec 4, 2020), Seer (up 247.4%, offer date Dec 3, 2020), Kinnate Biopharma (up 126.3%, offer date Dec 2, 2020), Olema Pharmaceuticals (up 130.1%, offer date Nov 18, 2020), Praxis (up 124.3%, offer date Oct 15, 2020) are some that have seen a huge surge in returns from IPO.
Food & Lodging Hogging the IPO Limelight at Present
Many IPOs have seen huge success this year with the largest provider of food delivery services DoorDash DASH grabbing attention currently.The stock gained 86% on its debut on Dec 9. Its $102 IPO price breezed past the estimated price range of $90 to $95.
Most importantly, the company initially filed to offer at a range of $75 to $85. The stock closed its first day on the New York Stock Exchange at $189 per share. Overall, DoorDash raised $3.4 billion with an initial public offering.
Apart from DoorDash, Airbnb ABNB is making quite a buzz. Its shares are likely to begin trading from Dec 10. It reportedly priced its initial public offering at $68 per share, in one of this year’s largest and highly anticipated IPOs.
Before this, Airbnb had planned to sell around 51 million shares at $56 to $60 per share, having boosted this range from an earlier target of $44 to $50 per share, per Reuters. The outlook looks promising for the company as with virus concerns prevailing, many travelers may be intending to book homes instead of hotels.
How to Invest?
Overall, the IPO pipeline is still solid. SPAC activity maintained the winning momentum. Against this backdrop, investors can bet on the following ETFs.
Defiance NextGen SPAC IPO ETF
The underlying Indxx SPAC & NextGen IPO Index of the fund SPAK tracks the performance of the common stock of newly listed Special Purpose Acquisition Companies (SPACs), ex-warrants, and IPOs derived from Acquisition Companies over the preceding 36 months.
An 80% weighting is attached to IPO companies derived from SPACs and 20% is allocated to the common stocks of newly listed Special Purpose Acquisition Companies. The fund charges 45 bps in fees.
Renaissance IPO ETF (IPO - Free Report) )
The underlying Renaissance IPO Index is a portfolio of newly U.S.-listed IPOs of companies whose unseasoned equities are under-represented in core U.S. equity indices. Notably, IPOs that meet liquidity & operational screens are included on the index at the end of the fifth day of trading, or upon quarterly reviews, weighted by tradable float, capped at 10% and removed after two years. The fund charges 60 bps in fees.
Renaissance International IPO ETF (IPOS - Free Report)
The underlying Renaissance International IPO Index is a stock market index based upon a portfolio of non-U.S.-listed newly public companies, prior to their inclusion in global core equity portfolios. The fund charges 80 bps in fees. The fund charges 80 bps in fees.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>